Bloomberg Television
@markets·3.2M subscribers·95.6K videos
Novo Going 'All-In' With Wegovy Weight Loss Pill
Posted
December 23, 2025
Views
3,246
Likes
18
Comments
6
Engagement
0.74%
December 23, 2025
3,246
18
6
0.74%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:19Now PlayingThe US will let Novo Nordisk A/S sell it blockbuster weight loss drug Wegovy in a pill form. Millions of people already take the shot. A trial showed people taking a 25 milligram pill once daily lost about 13.6% of their body weight over 64 weeks. Novo President and CEO Mike Doustdar speaks to Bloomberg's Katie Greifeld.
--------
More on Bloomberg Television and Markets
Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance
Visit for business news & analysis, uptotheminute market data, features, profiles and more.
Connect with Bloomberg Television on:
Connect with Bloomberg Business on:
More from Bloomberg:
Bloomberg Radio
Bloomberg Surveillance
Bloomberg Politics
Bloomberg Originals
Watch more on YouTube:
Bloomberg Technology
Bloomberg Originals
Bloomberg Quicktake
Bloomberg Espanol
Bloomberg Podcasts
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
